A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB.

by Markus Beutler, Sara Plesnik, Marina Mihalic, Laura Olbrich, Norbert Heinrich, Samuel Schumacher, Michael Lindner, Ina Koch, Wolfgang Grasse, Christoph Metzger-Boddien, Sabine Hofmann-Thiel, Harald Hoffmann
Published 2020-01-01